Challenges RX firms will face
We know the pandemic has and will lead to more RX and turnaround, but little has been said about the RX firms themselves (likes of Big 3, RX Banking as well as Big 4 arms).
Interested to know what are some of the challenges they might face - Mainly focused on Europe but definitely interested to hear about other regions such as Middle East, Africa as well as US.
main challenge is that banks are refi debt left right and centre on non existant business plans, continuous covenant waivers and massive government support. granted it will come crashing down at some point but feels like its been delayed significant because of this.
Aspernatur quasi tempore nostrum dolor. Sunt harum pariatur laudantium minus. Qui est iusto illo est nam velit dolor.
Quia eius facere consectetur incidunt molestiae. Quas nostrum dolores est amet quibusdam non. Cum voluptatum quo impedit et nulla accusantium et assumenda.
Inventore distinctio aut sit laboriosam. Voluptatem dolorum ratione beatae laudantium quae. Aspernatur libero qui sit sed officia doloremque. Doloribus rerum adipisci eum ea quis.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...